title: [Diagnostic imaging methods of cardiac dysfunction caused by cardiotoxicity of oncological therapy].
abstract: Cardiotoxicity of chemotherapy is a serious complication of oncological treatment. Assessment of cardiac function before, during and after cardiotoxic chemotherapy course should be a standard procedure in oncology. There are several methods for evaluation of the changes in myocardium such as: electrocardiography, radiology techniques (RTG, CT, MRI, PET-CT, PET-MRI), echocardiography, radioisotope imaging techniques (scyntygraphy, MUGA, PET), and ultra-structure evaluation in biopsy samples. Nevertheless, there is a continuous need for new diagnostic methods of cardiac dysfunction of great predictive and prognostic importance. Unfortunately advanced imaging techniques are still not available in many oncological centers in Poland. Nowadays to evaluate potential cardiotoxicity of drugs in oncology it is postulated to perform serial echocardiographic examinations as a basal imaging method. Thus constant cooperation between cardiologist and oncologist plays crucial role during chemotherapy.
authors.affiliation: Department of Coronary Disease and Heart Failure, Institute of Cardiology, Jagiellonian University, Medical College, John Paul II Hospital, Cracow, Poland.
authors.forename: Maria
authors.initials: M
authors.lastname: Lelakowska-Pieła
authors.affiliation: Oncology Department, Jagiellonian University, Medical College, Cracow, Poland.
authors.forename: Agnieszka
authors.initials: A
authors.lastname: Słowik
authors.affiliation: Department of Coronary Disease and Heart Failure, Institute of Cardiology, Jagiellonian University, Medical College, John Paul II Hospital, Cracow, Poland.
authors.forename: Anna
authors.initials: A
authors.lastname: Kozynacka
authors.affiliation: Department of Coronary Disease and Heart Failure, Institute of Cardiology, Jagiellonian University, Medical College, John Paul II Hospital, Cracow, Poland.
authors.forename: Maciej
authors.initials: M
authors.lastname: Panek
authors.affiliation: Department of Coronary Disease and Heart Failure, Institute of Cardiology, Jagiellonian University, Medical College, John Paul II Hospital, Cracow, Poland.
authors.forename: Ewa
authors.initials: E
authors.lastname: Konduracka
authors.affiliation: Department of Coronary Disease and Heart Failure, Institute of Cardiology, Jagiellonian University, Medical College, John Paul II Hospital, Cracow, Poland.
authors.forename: Jadwiga
authors.initials: J
authors.lastname: Nessler
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use* / Q000633:toxicity*; D066126:Cardiotoxicity / Q000175:diagnosis*; D004452:Echocardiography; D004562:Electrocardiography; D006321:Heart / Q000187:drug effects*; D006801:Humans; D008279:Magnetic Resonance Imaging; D009369:Neoplasms / Q000188:drug therapy*; D011044:Poland; D011379:Prognosis
chemical_list: D000970:Antineoplastic Agents
keywords: cardiotoxicity; chemotherapy cardiac dysfunction